Abstracts
Objective: The effects on cell-cycle and p53 expression in hepatoma cell line SK-Hep-1 were explored by transfecting exogenous p53 small double stranded RNA (dsRNA) into the SK-Hep-1 cells. Methods: p53 dsRNA and EGFP dsRNA were synthesized. SK-Hep-1 (wtp53) cell line was transfected with 200 ng and 400 ng p53 dsRNA or EGFP and EGFP+EGFP dsRNA (as positive control) or 9% NaCl (as blank control) by liposome transfection technique. Flow cytometry was adopted to measure the effects of p53 dsRNA on cell cycle. Expression of p53 protein was detected by Western-Blotting at 48 h after transfecting p53 dsRNA. Results: The number of G0–G1 phase SK-Hep-1 cells, which were transfected with 200 ng p53 dsRNA, was decreased by 52.53% comparing with the control, and decreased by 50.29% (P<0.05) comparing with the positive control cells transfected with same dosage of EGFP+EGFP dsRNA. The number of S phase cells, which were transfected with 200 ng p53 dsRNA, was increased by 146.8% comparing with the control, and increased by 128.62% (P<0.05) comparing with the positive control cells transfected with same dosage of EGFP+EGFP dsRNA. The number of G2-M phase cells, which were transfected with 200 ng p53 dsRNA, was increased by 30.56% (P<0.05) comparing with the control, and increased by 21.63% (P>0.05) comparing with the positive control cells transfected with same dosage of EGFP+EGFP dsRNA. After 48 h, p53 protein expression was not detected in the SK-Hep-1 cells transfected with p53 dsRNA. Conclusion: p53 dsRNA can obviously improve the proliferation of SK-Hep-1 cells, and suppress p53 protein expression of SK-Hep-1 cells, the former may be related to of the latter.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Knudson AG Jr. Mutation and cancer: statistical study of Retinoblastoma [J]. Proc Natl Acad Sci USA 1971; 68:820–3.
Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers [J]. Science 1991; 253:49–53.
Staib F, Hussain SP, Hofseth LJ, et al. p53 and liver carcinogenesis [J]. Hum Mutat 2003; 21:201–6.
Montgomery MK, Xu S, Fire A. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans [J]. Proc Natl Acad Sci USA 1998; 22:15502–7.
Tuschl T, Zamore PD, Lehmann R, et al. Targeted mRNA degradation by double- stranded RNA in vitro [J]. Genes Dev 1999; 13:3191–7.
Martinez LA, Naguibneva I, Lehrmann H, et al. Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways [J]. Proc Natl Acad Sci USA 2002; 99:14849–54.
Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells [J]. Science 2002; 296:550–3.
Elbashir SM, Harborth J, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs [J]. Methods 2002; 26:199–213.
Puisieux A, Galvin K, Troalen F, et al. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines [J]. FASEB J 1993; 7:1407–13.
Bates S, Vousden KH. Mechanisms of p53-mediated apoptosis [J]. Cell Mol Life Sci 1999; 55:28–37.
Levine AJ. p53, the cellular gatekeeper for growth and division [J]. Cell 1997; 88:323-.31.
Author information
Authors and Affiliations
Additional information
Foundation item: This work was supported by the National Postdoctoral Science Foundation of China (No. 2003034300).
Biography: CAO Xiao-zhe (1965–), male, postdoctor of medicine, Second Military Medical University, majors in molecule-pathology of liver carcinoma.
Rights and permissions
About this article
Cite this article
Cao, Xz., Zhu, Mh., Zhu, Z. et al. Influence of p53 small double stranded RNA interference on hepatoma cell line SK-HEP-1. Chin. J. Cancer Res. 17, 22–27 (2005). https://doi.org/10.1007/s11670-005-0005-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11670-005-0005-6